BMB Reports 2019; 52(3): 226-226  
Erratum to: MiR-363 inhibits cisplatin chemoresistance of epithelial ovarian cancer by regulating snail-induced epithelial-mesenchymal transition
Lanqin Cao1, Qian Wan1, Fengjie Li1 & Can-e Tang2,*
1Department of Obstetrics, Xiangya Hospital, Central South University, Changsha, Hunan 410008, 2The Institute of Medical Science
Research, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P. R., China
Correspondence to: Tel: +86-0731-84327628; Fax: +86-731-84327332; E-mail: csutangcane@163.com
Received: March 12, 2019; Published online: March 31, 2019.
© Korean Society for Biochemistry and Molecular Biology. All rights reserved.

cc This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract

The BMB Reports would like to correct in the Supplementary Figure 1 of BMB Rep. 51(9): 456-461 titled "MiR-363 inhibits cisplatin chemoresistance of epithelial ovarian cancer by regulating snail-induced epithelial-mesenchymal transition."

Erratum to: BMB Reports 2018; 51(9): 456-461, PMID: 30037365

Keywords: Erratum


This Article


Cited By Articles
  • CrossRef (0)

Services
Social Network Service

e-submission

Archives